Foresight Diagnostics to Showcase New Clinical Data on MRD Detection at the IASLC World Conference 2025 Foresight Diagnostics will present groundbreaking clinical data on its MRD detection technology at IASLC 2025, enhancing early-stage lung cancer insights.

Foresight Diagnostics to Showcase New Clinical Data on MRD Detection at the IASLC World Conference 2025 #United_States #Boulder #Lung_Cancer #MRD_Detection #Foresight_CLARITY

Foresight Diagnostics to Showcase Next-Gen MRD Detection Data at ASCO 2025 Annual Meeting Foresight Diagnostics will present groundbreaking data on ultra-sensitive minimal residual disease detection during the ASCO 2025 meeting, targeting improved cancer therapy outcomes.

Foresight Diagnostics to Showcase Next-Gen MRD Detection Data at ASCO 2025 Annual Meeting #United_States #Chicago #ASCO_2025 #Foresight_Diagnostics #MRD_Detection

Foresight Diagnostics Partners with Allogene to Enhance Global MRD Detection Efforts Foresight Diagnostics has deepened its collaboration with Allogene Therapeutics to advance minimal residual disease detection developments across multiple countries outside the U.S.

Foresight Diagnostics Partners with Allogene to Enhance Global MRD Detection Efforts #USA #Boulder #Foresight_Diagnostics #Allogene_Therapeutics #MRD_Detection